Atyr Pharma Inc. (LIFE) NASDAQ
$1.91 0.03 (1.60%)
Market Cap: $99.94M
As of 03/24/23 03:59 PM EDT. Market closed.
Atyr Pharma Inc. (LIFE)
NASDAQ
$1.91
0.03 (1.60%)
Market Cap: $99.94M
As of 03/24/23 03:59 PM EDT. Market closed.
aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of ... read more
aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in inflammatory lung diseases. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Sanjay Shukla
Full Time Employees
53
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Sanjay Shukla
Full Time Employees
53
Address
3545 John Hopkins Ct Ste 250, California, San Diego, 92121-1115.
PRICE CHART FOR ATYR PHARMA INC
From:
To:
NEWS
KEY STATS
Open
$1.86
Previous Close
$1.88
Days Range
$1.83 - $1.91
52 week range
$1.82 - $6.08
Volume
81,517
Avg. Volume (30 days)
243,470
Market Cap
$99.94M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
53,162,052
Open
$1.86
Previous Close
$1.88
Days Range
$1.83 - $1.91
52 week range
$1.82 - $6.08
Volume
81,517
Avg. Volume (30 days)
243,470
Market Cap
$99.94M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
53,162,052
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ATYR PHARMA INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Broadfoot Jill Marie | Chief Financial Officer | Feb 06, 2023 | Sale | $2.36 | 1,566 | 3,696 | 15,460 | Feb 06, 2023, 07:00 PM |
| Shukla Sanjay | President and CEO | Nov 21, 2022 | Buy | $2.14 | 10,000 | 21,405 | 50,798 | Nov 21, 2022, 09:04 PM |
| Shukla Sanjay | President and CEO | Jul 01, 2022 | Buy | $2.88 | 15,000 | 43,164 | 40,798 | Jul 06, 2022, 05:02 PM |
| Broadfoot Jill Marie | Chief Financial Officer | Jan 13, 2022 | Buy | $6.75 | 1,923 | 12,980 | 12,112 | Jan 18, 2022, 08:39 AM |
| Shukla Sanjay | President and CEO | Jan 07, 2022 | Buy | $6.76 | 5,000 | 33,807 | 25,798 | Jan 10, 2022, 08:03 PM |
| Shukla Sanjay | President and CEO | Nov 15, 2021 | Buy | $8.57 | 2,500 | 21,437 | 20,798 | Nov 15, 2021, 06:56 PM |
| SCHIMMEL PAUL | Director | Sep 20, 2021 | Buy | $8.00 | 250,000 | 2,000,000 | 252,890 | Sep 22, 2021, 08:19 PM |
| SCHIMMEL PAUL | Director | May 18, 2021 | Buy | $3.98 | 50,000 | 199,000 | 113,023 | May 20, 2021, 08:55 AM |
| Shukla Sanjay | President and CEO | May 18, 2021 | Buy | $4.01 | 10,000 | 40,100 | 18,298 | May 20, 2021, 08:52 AM |
| Broadfoot Jill Marie | Chief Financial Officer | Feb 09, 2021 | Sale | $7.66 | 390 | 2,987 | 9,833 | Feb 09, 2021, 09:15 PM |
| Shukla Sanjay | President and CEO | Feb 09, 2021 | Sale | $7.66 | 778 | 5,959 | 8,298 | Feb 09, 2021, 09:12 PM |
| CLARKE JOHN K | Director | Sep 02, 2020 | Sale | $4.01 | 7,260 | 29,113 | 110,583 | Sep 03, 2020, 09:47 PM |
| CLARKE JOHN K | Director | Aug 28, 2020 | Sale | $4.00 | 100 | 400 | 117,843 | Sep 03, 2020, 09:47 PM |
| CLARKE JOHN K | Director | Aug 27, 2020 | Sale | $4.09 | 5,440 | 22,250 | 117,943 | Aug 28, 2020, 09:09 PM |
| CLARKE JOHN K | Director | Aug 26, 2020 | Sale | $4.30 | 2,200 | 9,451 | 123,383 | Aug 28, 2020, 09:09 PM |
| Broadfoot Jill Marie | Chief Financial Officer | Jun 19, 2020 | Buy | $4.22 | 1,850 | 7,807 | 9,153 | Jun 23, 2020, 04:27 PM |
| Shukla Sanjay | President and CEO | Jun 19, 2020 | Buy | $4.27 | 6,000 | 25,620 | 7,291 | Jun 23, 2020, 04:23 PM |
| DENYES NANCY | General Counsel | May 20, 2020 | Sale | $3.62 | 322 | 1,166 | 2,735 | May 28, 2020, 08:26 PM |
| SCHIMMEL PAUL | Director | May 20, 2020 | Sale | $3.64 | 8,447 | 30,739 | 429,143 | May 22, 2020, 08:13 PM |
| SCHIMMEL PAUL | Director | Feb 10, 2020 | Buy | $4.25 | 254,000 | 1,079,500 | 437,590 | Feb 11, 2020, 11:58 AM |
| Shukla Sanjay | President and CEO | Feb 07, 2020 | Sale | $4.03 | 745 | 3,002 | 1,291 | Feb 07, 2020, 07:37 PM |
| Broadfoot Jill Marie | Chief Financial Officer | Feb 07, 2020 | Sale | $4.03 | 375 | 1,511 | 7,125 | Feb 07, 2020, 07:30 PM |
| Krueger Nancy | General Counsel | May 17, 2019 | Sale | $0.45 | 4,651 | 2,093 | 25,348 | May 20, 2019, 04:38 PM |
| SCHIMMEL PAUL | Director | Apr 12, 2019 | Option Exercise | $0.54 | 1,848,428 | 1,000,000 | 2,570,242 | Apr 16, 2019, 04:31 PM |
| MENDLEIN JOHN | Director | Dec 21, 2018 | Buy | $0.42 | 195,000 | 82,602 | 615,382 | Dec 26, 2018, 04:15 PM |
| MENDLEIN JOHN | Director | Dec 20, 2018 | Buy | $0.41 | 50,000 | 20,645 | 420,382 | Dec 26, 2018, 04:15 PM |
| SCHIMMEL PAUL | Director | Nov 26, 2018 | Buy | $0.54 | 147,225 | 79,796 | 882,302 | Nov 28, 2018, 07:12 PM |
| Broadfoot Jill Marie | Chief Financial Officer | Sep 20, 2018 | Buy | $0.84 | 38,000 | 31,738 | 90,000 | Sep 21, 2018, 04:38 PM |
| Broadfoot Jill Marie | Chief Financial Officer | Sep 19, 2018 | Buy | $0.81 | 26,000 | 21,117 | 52,000 | Sep 21, 2018, 04:38 PM |
| Broadfoot Jill Marie | Chief Financial Officer | Sep 14, 2018 | Buy | $0.73 | 26,000 | 19,055 | 26,000 | Sep 18, 2018, 06:12 PM |
| SCHIMMEL PAUL | Director | Sep 04, 2018 | Buy | $0.76 | 20,749 | 15,709 | 735,077 | Sep 05, 2018, 04:04 PM |
| SCHIMMEL PAUL | Director | Aug 31, 2018 | Buy | $0.72 | 22,000 | 15,752 | 714,328 | Sep 05, 2018, 04:04 PM |
| SCHIMMEL PAUL | Director | Aug 30, 2018 | Buy | $0.76 | 89,275 | 67,483 | 692,328 | Aug 31, 2018, 04:11 PM |
| SCHIMMEL PAUL | Director | Aug 29, 2018 | Buy | $0.72 | 75,136 | 54,090 | 603,053 | Aug 31, 2018, 04:11 PM |
| SCHIMMEL PAUL | Director | May 18, 2018 | Buy | $1.00 | 150,000 | 149,445 | 527,917 | May 21, 2018, 06:50 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | May 15, 2018 | Sale | $1.43 | 121,294 | 173,062 | 2,733,231 | May 16, 2018, 05:15 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | May 14, 2018 | Sale | $1.72 | 354,791 | 609,070 | 2,854,525 | May 16, 2018, 05:15 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | May 16, 2018 | Sale | $0.81 | 2,733,231 | 2,216,924 | 0 | May 16, 2018, 05:15 PM |
| Blake John T | Senior Vice President, Finance | Feb 08, 2018 | Sale | $3.40 | 1,402 | 4,767 | 1,932 | Feb 08, 2018, 08:43 PM |
| Amanullah Ashraf | See Remarks | Feb 08, 2018 | Sale | $3.40 | 1,402 | 4,767 | 1,932 | Feb 08, 2018, 08:39 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | Nov 01, 2017 | Buy | $4.80 | 24,728 | 118,694 | 3,223,148 | Dec 14, 2017, 03:46 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | Oct 01, 2017 | Buy | $5.05 | 4,879 | 24,639 | 3,198,420 | Dec 14, 2017, 03:46 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | Nov 08, 2017 | Sale | $4.30 | 1,070 | 4,601 | 3,222,078 | Dec 14, 2017, 03:46 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | Nov 13, 2017 | Sale | $3.95 | 1,083 | 4,278 | 3,209,316 | Dec 14, 2017, 03:46 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | Nov 10, 2017 | Sale | $4.00 | 5,860 | 23,445 | 3,210,399 | Dec 14, 2017, 03:46 PM |
| EcoR1 Capital Fund Qualified, L.P. | 10% Owner | Nov 09, 2017 | Sale | $4.15 | 5,819 | 24,151 | 3,216,259 | Dec 14, 2017, 03:46 PM |
| SCHIMMEL PAUL | Director | Aug 31, 2017 | Buy | $2.65 | 94,336 | 249,990 | 377,917 | Sep 05, 2017, 08:22 PM |
| MENDLEIN JOHN | CEO and Director | Aug 31, 2017 | Buy | $2.65 | 37,736 | 100,000 | 367,883 | Sep 05, 2017, 07:41 PM |
| MENDLEIN JOHN | CEO and Director | Apr 24, 2017 | Buy | $3.00 | 124 | 372 | 327,647 | Apr 26, 2017, 05:02 PM |
| MENDLEIN JOHN | CEO and Director | Apr 20, 2017 | Buy | $3.00 | 1,552 | 4,656 | 327,523 | Apr 20, 2017, 07:04 PM |
| MENDLEIN JOHN | CEO and Director | Apr 18, 2017 | Buy | $3.00 | 1,000 | 3,000 | 325,971 | Apr 20, 2017, 07:04 PM |
| SCHIMMEL PAUL | Director | Dec 21, 2016 | Buy | $2.28 | 10,000 | 22,818 | 721,814 | Dec 22, 2016, 11:53 AM |
| SCHIMMEL PAUL | Director | Dec 20, 2016 | Buy | $2.27 | 15,000 | 34,110 | 711,814 | Dec 22, 2016, 11:53 AM |
| Amanullah Ashraf | Vice President, Manufacturing | Dec 20, 2016 | Buy | $2.25 | 11,000 | 24,749 | 11,000 | Dec 21, 2016, 06:37 PM |
| MENDLEIN JOHN | CEO and Director | Dec 19, 2016 | Buy | $2.20 | 69,000 | 151,662 | 324,971 | Dec 21, 2016, 11:54 AM |
| SCHIMMEL PAUL | Director | Dec 16, 2016 | Buy | $2.40 | 10,000 | 23,973 | 696,814 | Dec 19, 2016, 07:41 PM |
| SCHIMMEL PAUL | Director | Dec 15, 2016 | Buy | $2.50 | 40,000 | 99,912 | 686,814 | Dec 19, 2016, 07:41 PM |
| Matsuoka Grove | See Remarks | May 11, 2016 | Buy | $3.03 | 10,000 | 30,300 | 12,412 | May 11, 2016, 08:54 PM |
| Matsuoka Grove | See Remarks | May 09, 2016 | Buy | $3.08 | 2,412 | 7,429 | 2,412 | May 11, 2016, 08:54 PM |
| SCHIMMEL PAUL | Director | Apr 14, 2016 | Buy | $4.14 | 32,600 | 135,075 | 53,012 | Apr 15, 2016, 05:46 PM |
| SCHIMMEL PAUL | Director | Apr 14, 2016 | Buy | $4.22 | 33,619 | 141,859 | 283,581 | Apr 15, 2016, 05:46 PM |
| SCHIMMEL PAUL | Director | Apr 13, 2016 | Buy | $3.85 | 9,835 | 37,865 | 249,962 | Apr 14, 2016, 07:20 PM |
| SCHIMMEL PAUL | Director | Apr 12, 2016 | Buy | $3.70 | 6,546 | 24,220 | 240,127 | Apr 13, 2016, 06:34 PM |
| SCHIMMEL PAUL | Director | Apr 12, 2016 | Buy | $3.75 | 2,581 | 9,682 | 20,412 | Apr 13, 2016, 06:34 PM |
| SCHIMMEL PAUL | Director | Apr 11, 2016 | Buy | $3.56 | 27,400 | 97,643 | 233,581 | Apr 13, 2016, 06:32 PM |
| SCHIMMEL PAUL | Director | Apr 11, 2016 | Buy | $3.59 | 5,259 | 18,891 | 17,831 | Apr 13, 2016, 06:32 PM |
| SCHIMMEL PAUL | Director | Apr 11, 2016 | Buy | $3.57 | 32,659 | 116,535 | 220,231 | Apr 12, 2016, 03:57 PM |
| SCHIMMEL PAUL | Director | Apr 08, 2016 | Buy | $3.22 | 85,000 | 273,649 | 187,572 | Apr 11, 2016, 12:39 PM |
| SCHIMMEL PAUL | Director | Apr 07, 2016 | Buy | $3.19 | 40,000 | 127,584 | 102,572 | Apr 08, 2016, 12:19 PM |
| SCHIMMEL PAUL | Director | Apr 06, 2016 | Buy | $3.20 | 25,000 | 80,000 | 62,572 | Apr 07, 2016, 03:40 PM |
| MENDLEIN JOHN | CEO and Director | Apr 05, 2016 | Buy | $3.52 | 2,500 | 8,800 | 250,971 | Apr 07, 2016, 03:25 PM |
| MENDLEIN JOHN | CEO and Director | Apr 05, 2016 | Buy | $3.55 | 2,500 | 8,875 | 248,471 | Apr 06, 2016, 07:19 PM |
| SCHIMMEL PAUL | Director | Apr 05, 2016 | Buy | $3.52 | 25,000 | 88,117 | 37,572 | Apr 06, 2016, 07:19 PM |
| AKKARAJU SRINIVAS | Director | May 12, 2015 | Buy | $14.00 | 320,000 | 4,480,000 | 1,866,126 | May 14, 2015, 09:24 PM |
| Sofinnova Venture Partners IX, L.P. | 10% Owner | May 12, 2015 | Buy | $14.00 | 320,000 | 4,480,000 | 1,866,126 | May 14, 2015, 09:19 PM |
| Flynn James E | 10% Owner | May 12, 2015 | Buy | $14.00 | 25,000 | 350,000 | 255,764 | May 13, 2015, 01:00 PM |
| Flynn James E | 10% Owner | May 12, 2015 | Buy | $14.00 | 25,000 | 350,000 | 255,764 | May 13, 2015, 01:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN ATYR PHARMA INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 268,946 | 0.00002% | 0.69% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 242,239 | 0.00007% | 1.15% | Other |
| BAKER BROS. ADVISORS LP | 8,565 | 0.00011% | -95.75% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 166,076 | 0.0005% | -11.44% | Other |
CHANGE IN SHARES OUTSTANDING FOR ATYR PHARMA INC
STOCK BUYBACKS FOR ATYR PHARMA INC
Load More
Period of Report: 12/31/2022
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
0.83%
1Q
06/30/2022
1.71%
2Q
12/31/2021
48.94%
4Q
03/31/2019
-15.98%
15Q
12/31/2018
-5.13%
16Q
Load More